This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1996 Oct 15;93(21):11287.

doi: 10.1073/pnas.93.21.11287.

Genetic engineering of viruses and of virus vectors: a preface

P Palese¹, B Roizman

Affiliations

PMID: 8876127
PMCID: PMC38049
DOI: 10.1073/pnas.93.21.11287

Free PMC article

Genetic engineering of viruses and of virus vectors: a preface

P Palese et al. Proc Natl Acad Sci U S A. 1996.

Free PMC article

. 1996 Oct 15;93(21):11287.

doi: 10.1073/pnas.93.21.11287.

Authors

P Palese¹, B Roizman

Affiliation

¹ Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029, USA.

PMID: 8876127
PMCID: PMC38049
DOI: 10.1073/pnas.93.21.11287

No abstract available

PubMed Disclaimer

Similar articles

Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells.
Campbell SA, Gromeier M. Campbell SA, et al. Onkologie. 2005 Apr;28(4):209-15. doi: 10.1159/000084010. Epub 2005 Mar 31. Onkologie. 2005. PMID: 15840970 Review.
Oncolytic viruses.
Chiocca EA. Chiocca EA. Nat Rev Cancer. 2002 Dec;2(12):938-50. doi: 10.1038/nrc948. Nat Rev Cancer. 2002. PMID: 12459732 Review.
Virus vector-mediated gene transfer.
Levine AJ. Levine AJ. Microbiol Sci. 1987 Aug;4(8):245-50. Microbiol Sci. 1987. PMID: 3155277 Review.
The viruses don't always read the books: engineered vaccines and gene therapy using viral vectors.
Strayer DS. Strayer DS. Lab Invest. 1994 Sep;71(3):319-23. Lab Invest. 1994. PMID: 7933983 Review. No abstract available.
Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
Hermiston TW, Kuhn I. Hermiston TW, et al. Cancer Gene Ther. 2002 Dec;9(12):1022-35. doi: 10.1038/sj.cgt.7700542. Cancer Gene Ther. 2002. PMID: 12522441 Review.

See all similar articles

Cited by

The Development of Methods for the Production of New Molecular Vaccines and Appropriate RNA Fragments to Counteract Unwanted Genes: A Pilot Study.
Sainova I, Kolyovska V, Ilieva I, Markova T, Dimitrova-Dikanarova D, Hadjiolova R. Sainova I, et al. Vaccines (Basel). 2023 Jul 11;11(7):1226. doi: 10.3390/vaccines11071226. Vaccines (Basel). 2023. PMID: 37515042 Free PMC article.
Silencing Transcription from an Influenza Reverse Genetics Plasmid in E. coli Enhances Gene Stability.
Malik T, Klenow L, Karyolaimos A, Gier JW, Daniels R. Malik T, et al. ACS Synth Biol. 2023 Feb 17;12(2):432-445. doi: 10.1021/acssynbio.2c00358. Epub 2023 Jan 30. ACS Synth Biol. 2023. PMID: 36716395 Free PMC article.
Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer.
Muley H, Valencia K, Casas J, Moreno B, Botella L, Lecanda F, Fadó R, Casals N. Muley H, et al. Int J Mol Sci. 2023 Jan 4;24(2):946. doi: 10.3390/ijms24020946. Int J Mol Sci. 2023. PMID: 36674468 Free PMC article.
Reconsidering the need for gain-of-function research on enhanced potential pandemic pathogens in the post-COVID-19 era.
Shinomiya N, Minari J, Yoshizawa G, Dando M, Shang L. Shinomiya N, et al. Front Bioeng Biotechnol. 2022 Aug 26;10:966586. doi: 10.3389/fbioe.2022.966586. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36091454 Free PMC article.
RNA virus vectors: where are we and where do we need to go?
Palese P. Palese P. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12750-2. doi: 10.1073/pnas.95.22.12750. Proc Natl Acad Sci U S A. 1998. PMID: 9788984 Free PMC article. Review. No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources